The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council New South Wales, Kings Cross, P O Box 572, Sydney, NSW, 1340, Australia.
Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
J Cancer Res Clin Oncol. 2022 Nov;148(11):2971-2984. doi: 10.1007/s00432-021-03856-4. Epub 2021 Nov 25.
We quantified the contributions of prognostic factors to socioeconomic disparities in colorectal cancer survival in a large Australian cohort.
The sample comprised 45 and Up Study participants (recruited 2006-2009) who were subsequently diagnosed with colorectal cancer. Both individual (education attained) and neighbourhood socioeconomic measures were used. Questionnaire responses were linked with cancer registrations (to December 2013), records for hospital inpatient stays, emergency department presentations, death information (to December 2015), and Medicare and Pharmaceutical Benefits claims for subsidised procedures and medicines. Proportions of socioeconomic survival differences explained by prognostic factors were quantified using multiple Cox proportional hazards regression.
1720 eligible participants were diagnosed with colorectal cancer after recruitment: 1174 colon and 546 rectal cancers. Significant colon cancer survival differences were only observed for neighbourhood socioeconomic measure (p = 0.033): HR = 1.55; 95% CI 1.09-2.19 for lowest versus highest quartile, and disease-related factors explained 95% of this difference. For rectal cancer, patient- and disease-related factors were the main drivers of neighbourhood survival differences (28-36%), while these factors and treatment-related factors explained 24-41% of individual socioeconomic differences. However, differences remained significant for rectal cancer after adjusting for all these factors.
In this large contemporary Australian cohort, we identified several drivers of socioeconomic disparities in colorectal cancer survival. Understanding of the role these contributors play remains incomplete, but these findings suggest that improving access to optimal care may significantly reduce these survival disparities.
我们在一个大型澳大利亚队列中定量评估了预后因素对结直肠癌生存的社会经济差异的贡献。
样本包括参加了 45 岁及以上研究(2006-2009 年招募)的参与者,这些参与者随后被诊断患有结直肠癌。个体(获得的教育)和社区社会经济指标都被使用。问卷调查的答复与癌症登记(截至 2013 年 12 月)、医院住院记录、急诊室就诊记录、死亡信息(截至 2015 年 12 月)以及医疗保险和药品福利计划(用于补贴程序和药物)记录相关联。使用多 Cox 比例风险回归来量化预后因素解释社会经济生存差异的比例。
在招募后,有 1720 名合格的参与者被诊断患有结直肠癌:1174 例结肠癌和 546 例直肠癌。仅观察到社区社会经济指标对结肠癌生存存在显著差异(p=0.033):HR=1.55;95%CI 1.09-2.19,最低与最高四分位数之间,疾病相关因素解释了这一差异的 95%。对于直肠癌,患者和疾病相关因素是社区生存差异的主要驱动因素(28-36%),而这些因素和治疗相关因素解释了个体社会经济差异的 24-41%。然而,在调整了所有这些因素后,直肠癌的差异仍然显著。
在这个大型当代澳大利亚队列中,我们确定了几种导致结直肠癌生存的社会经济差异的驱动因素。对这些贡献者所扮演角色的理解仍不完整,但这些发现表明,改善获得最佳治疗的机会可能会显著减少这些生存差异。